Both external and internal advisory committees have been established in order to optimize the SKCCC's success and to provide comprehensive, expert direction for our research activities. The Director seeks external advice to guide the development and direction of the SKCCC from a variety of sources, including the leadership of the University and Hospital, ad hoc consultants, and an External Advisory Board. Several internal advisory committees assist the Cancer Center in strategic and program planning, resource allocation, and identifying new initiatives and opportunities. The governance of the SKCCC is aimed at two major objectives: 1) maximizing the use of Cancer Center resources (human and physical) to achieve research goals;and 2) creating an efficient, effective, responsive and collegial enterprise. These committee include: 1) Executive Committee;2) Research Council;3) Protocol Review and Monitoring Committee 4) Safety Monitoring Committee;5) Laboratory Shared Resources Committee and 6) Clinical Research Operations Committee. The External Advisory Board (EAB) is composed of national leaders representing major areas of cancer research from preeminent institutions other than Johns Hopkins. This Advisory Board has played a critical role in the evaluation of scientific programs as well as assessment of the programmatic structure of this Cancer Center. Members of this Advisory Board have also been generous of their time in providing individual consultations in specific areas of their expertise.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-50
Application #
8559775
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
50
Fiscal Year
2013
Total Cost
$63,056
Indirect Cost
$24,132
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zeidner, Joshua F; Zahurak, Marianna; Rosner, Gary L et al. (2015) The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leuk Lymphoma 56:128-34
Penet, Marie-France; Shah, Tariq; Bharti, Santosh et al. (2015) Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 21:386-95
Sharabi, Andrew B; Nirschl, Christopher J; Kochel, Christina M et al. (2015) Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunol Res 3:345-55
DeZern, Amy E; Guinan, Eva C (2014) Aplastic anemia in adolescents and young adults. Acta Haematol 132:331-9
Paller, Channing J; Wissing, Michel D; Mendonca, Janet et al. (2014) Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. Cancer Med 3:1322-35
Maldonado, Leonel; Teague, Jessica E; Morrow, Matthew P et al. (2014) Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med 6:221ra13
Peltonen, Karita; Colis, Laureen; Liu, Hester et al. (2014) A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 25:77-90
Huang, Peng; Ou, Ai-hua; Piantadosi, Steven et al. (2014) Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials 39:294-302
Bhatnagar, Akrita; Wang, Yuchuan; Mease, Ronnie C et al. (2014) AEG-1 promoter-mediated imaging of prostate cancer. Cancer Res 74:5772-81
Cebulla, Jana; Kim, Eugene; Rhie, Kevin et al. (2014) Multiscale and multi-modality visualization of angiogenesis in a human breast cancer model. Angiogenesis 17:695-709

Showing the most recent 10 out of 357 publications